跳到正文
HSA 治疗药品召回·· 18 天前AI 评分51

HSA 公布 Agelmin 10 mg 片(西替利嗪)批次 231871 零售层面召回

Recall of Agelmin Tablet 10 mg (cetirizine)

AI 导读

HSA 公布 PHARMAKOE PTE LTD 的 Agelmin 10 mg 片(西替利嗪,注册号 SIN12396P)批次 231871 在零售层面召回,召回级别为 Class 2。召回日期为 2026 年 11 月 3 日,起因是 HSA 产品质量监测计划测试发现溶出度结果不符合规定。HSA 要求零售和批发供应商停止供应该批次,并将剩余库存退回公司。

正文 · 原文

Recall details

Date of Recall:

03 November 2026

Product:

AGELMIN TABLET 10 mg

Active Ingredient:

Cetirizine Dihydrochloride

Product Category:

Therapeutic Product

Registration number

SIN12396P

Batch No.:

231871

Class of Recall:

2

Level of Recall:

Retail

Local Company:

PHARMAKOE PTE LTD

Description of Issue:

Testing under HSA’s product quality surveillance programme identified out-of-specifications results for dissolution.

Recall instructions

Retail and wholesale suppliers:

Stop supplying the affected batch and return the remaining stocks to the company.

Enter a descriptive alt text.

Product image

Enter a descriptive alt text.

Product image

Note:

The Health Sciences Authority (HSA) publishes information regarding recalls of health products supplied in Singapore. These product recalls may be conducted on a company’s own initiative or upon HSA’s request to remove products where there are issues with quality, safety or efficacy. 

When a recall is initiated, it does not necessarily imply that a product is considered unsafe or is inefficacious. A recall can also be initiated to remove products with quality defects that does not impact safety or efficacy from the market so as to ensure that products registered in Singapore continue to meet the stringent regulatory standards stipulated by HSA.

Not all recalls will be publicly announced via press releases. When a recall involves a product that has been widely distributed or a product that poses a serious health risk, HSA will update the public through its channels, which may include its website, social media platforms or a press release.

Class of recall

A recall is classified as Class 1 or Class 2 depending on the potential hazard of the issue.

·       Class 1: For recalls of products with issues that can potentially cause serious adverse health outcomes or death.

·       Class 2: For recalls of products with issues that would not likely cause serious adverse health outcomes.

Level of recall

The level of product recall will depend on the potential hazard of the affected product, extent of distribution and whether other mitigating measures can be taken to address the issue.

1)      Consumer level: Affected product or batch(es) recalled from patients and consumers as well as wholesale suppliers, retail suppliers, hospitals, clinics and pharmacies.

2)      Retail level: Affected product or batch(es) recalled from retail suppliers, hospitals, clinics and pharmacies as well as wholesale suppliers.

3)      Wholesale level: Affected product or batch(es) recalled from wholesale suppliers.

来源:HSA 治疗药品召回 · hsa.gov.sg